How big is the Australia Self-Monitoring Blood Glucose Market?

The Australia Self-Monitoring Blood Glucose Market size is expected to reach USD 197.65 million in 2024 and grow at a CAGR of 5.5% to reach USD 258.33 million by 2029. Read More

What is the current Australia Self-Monitoring Blood Glucose Market size?

In 2024, the Australia Self-Monitoring Blood Glucose Market size is expected to reach USD 197.65 million. Read More

Who are the key players in Australia Self-Monitoring Blood Glucose Market?

Roche Diabetes Care, Abbott Diabetes Care, LifeScan, Arkray, Inc. and Ascensia Diabetes Care are the major companies operating in the Australia Self-Monitoring Blood Glucose Market. Read More

What years does this Australia Self-Monitoring Blood Glucose Market cover, and what was the market size in 2023?

In 2023, the Australia Self-Monitoring Blood Glucose Market size was estimated at USD 187.35 million. The report covers the Australia Self-Monitoring Blood Glucose Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Australia Self-Monitoring Blood Glucose Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Australia Self-Monitoring Blood Glucose Market Share

Statistics for the 2023 & 2024 Australia Self-Monitoring Blood Glucose market share, created by Mordor Intelligence™ Industry Reports. Australia Self-Monitoring Blood Glucose share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Australia Self-Monitoring Blood Glucose Industry

The Australia Self-Monitoring Blood Glucose Market is moderately fragmented, with few significant and other generic players. Manufacturers like Abbott, LifeScan, F. Hoffmann-La Roche AG, and Ascensia occupy a major share.